Global Peptide Therapy Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Peptide Therapy Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Peptide Therapy by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Peptide Therapy by Country/Region, 2017, 2022 & 2028

2.2 Peptide Therapy Segment by Type

2.2.1 Parenteral Route of Administration

2.2.2 Mucosal Route of Administration

2.2.3 Oral Route of Administration

2.2.4 Transdermal Route of Administration

2.3 Peptide Therapy Sales by Type

2.3.1 Global Peptide Therapy Sales Market Share by Type (2017-2022)

2.3.2 Global Peptide Therapy Revenue and Market Share by Type (2017-2022)

2.3.3 Global Peptide Therapy Sale Price by Type (2017-2022)

2.4 Peptide Therapy Segment by Application

2.4.1 Cancer

2.4.2 Cardiovascular Diseases

2.4.3 Gastrointestinal Disorders

2.4.4 Metabolic Disorders

2.4.5 Others

2.5 Peptide Therapy Sales by Application

2.5.1 Global Peptide Therapy Sale Market Share by Application (2017-2022)

2.5.2 Global Peptide Therapy Revenue and Market Share by Application (2017-2022)

2.5.3 Global Peptide Therapy Sale Price by Application (2017-2022)

3 Global Peptide Therapy by Company

3.1 Global Peptide Therapy Breakdown Data by Company

3.1.1 Global Peptide Therapy Annual Sales by Company (2020-2022)

3.1.2 Global Peptide Therapy Sales Market Share by Company (2020-2022)

3.2 Global Peptide Therapy Annual Revenue by Company (2020-2022)

3.2.1 Global Peptide Therapy Revenue by Company (2020-2022)

3.2.2 Global Peptide Therapy Revenue Market Share by Company (2020-2022)

3.3 Global Peptide Therapy Sale Price by Company

3.4 Key Manufacturers Peptide Therapy Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Peptide Therapy Product Location Distribution

3.4.2 Players Peptide Therapy Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Peptide Therapy by Geographic Region

4.1 World Historic Peptide Therapy Market Size by Geographic Region (2017-2022)

4.1.1 Global Peptide Therapy Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Peptide Therapy Annual Revenue by Geographic Region

4.2 World Historic Peptide Therapy Market Size by Country/Region (2017-2022)

4.2.1 Global Peptide Therapy Annual Sales by Country/Region (2017-2022)

4.2.2 Global Peptide Therapy Annual Revenue by Country/Region

4.3 Americas Peptide Therapy Sales Growth

4.4 APAC Peptide Therapy Sales Growth

4.5 Europe Peptide Therapy Sales Growth

4.6 Middle East & Africa Peptide Therapy Sales Growth

5 Americas

5.1 Americas Peptide Therapy Sales by Country

5.1.1 Americas Peptide Therapy Sales by Country (2017-2022)

5.1.2 Americas Peptide Therapy Revenue by Country (2017-2022)

5.2 Americas Peptide Therapy Sales by Type

5.3 Americas Peptide Therapy Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Peptide Therapy Sales by Region

6.1.1 APAC Peptide Therapy Sales by Region (2017-2022)

6.1.2 APAC Peptide Therapy Revenue by Region (2017-2022)

6.2 APAC Peptide Therapy Sales by Type

6.3 APAC Peptide Therapy Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Peptide Therapy by Country

7.1.1 Europe Peptide Therapy Sales by Country (2017-2022)

7.1.2 Europe Peptide Therapy Revenue by Country (2017-2022)

7.2 Europe Peptide Therapy Sales by Type

7.3 Europe Peptide Therapy Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Peptide Therapy by Country

8.1.1 Middle East & Africa Peptide Therapy Sales by Country (2017-2022)

8.1.2 Middle East & Africa Peptide Therapy Revenue by Country (2017-2022)

8.2 Middle East & Africa Peptide Therapy Sales by Type

8.3 Middle East & Africa Peptide Therapy Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Peptide Therapy

10.3 Manufacturing Process Analysis of Peptide Therapy

10.4 Industry Chain Structure of Peptide Therapy

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Peptide Therapy Distributors

11.3 Peptide Therapy Customer

12 World Forecast Review for Peptide Therapy by Geographic Region

12.1 Global Peptide Therapy Market Size Forecast by Region

12.1.1 Global Peptide Therapy Forecast by Region (2023-2028)

12.1.2 Global Peptide Therapy Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Peptide Therapy Forecast by Type

12.7 Global Peptide Therapy Forecast by Application

13 Key Players Analysis

13.1 Eli Lilly

13.1.1 Eli Lilly Company Information

13.1.2 Eli Lilly Peptide Therapy Product Offered

13.1.3 Eli Lilly Peptide Therapy Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Eli Lilly Main Business Overview

13.1.5 Eli Lilly Latest Developments

13.2 AstraZeneca

13.2.1 AstraZeneca Company Information

13.2.2 AstraZeneca Peptide Therapy Product Offered

13.2.3 AstraZeneca Peptide Therapy Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 AstraZeneca Main Business Overview

13.2.5 AstraZeneca Latest Developments

13.3 Merck

13.3.1 Merck Company Information

13.3.2 Merck Peptide Therapy Product Offered

13.3.3 Merck Peptide Therapy Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Merck Main Business Overview

13.3.5 Merck Latest Developments

13.4 Ipsen

13.4.1 Ipsen Company Information

13.4.2 Ipsen Peptide Therapy Product Offered

13.4.3 Ipsen Peptide Therapy Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Ipsen Main Business Overview

13.4.5 Ipsen Latest Developments

13.5 Novo Nordisk

13.5.1 Novo Nordisk Company Information

13.5.2 Novo Nordisk Peptide Therapy Product Offered

13.5.3 Novo Nordisk Peptide Therapy Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Novo Nordisk Main Business Overview

13.5.5 Novo Nordisk Latest Developments

13.6 Teva Pharmaceutical Industries

13.6.1 Teva Pharmaceutical Industries Company Information

13.6.2 Teva Pharmaceutical Industries Peptide Therapy Product Offered

13.6.3 Teva Pharmaceutical Industries Peptide Therapy Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Teva Pharmaceutical Industries Main Business Overview

13.6.5 Teva Pharmaceutical Industries Latest Developments

13.7 Abbott Laboratories

13.7.1 Abbott Laboratories Company Information

13.7.2 Abbott Laboratories Peptide Therapy Product Offered

13.7.3 Abbott Laboratories Peptide Therapy Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Abbott Laboratories Main Business Overview

13.7.5 Abbott Laboratories Latest Developments

13.8 Sanofi

13.8.1 Sanofi Company Information

13.8.2 Sanofi Peptide Therapy Product Offered

13.8.3 Sanofi Peptide Therapy Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Sanofi Main Business Overview

13.8.5 Sanofi Latest Developments

13.9 J & J

13.9.1 J & J Company Information

13.9.2 J & J Peptide Therapy Product Offered

13.9.3 J & J Peptide Therapy Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 J & J Main Business Overview

13.9.5 J & J Latest Developments

13.10 Novartis

13.10.1 Novartis Company Information

13.10.2 Novartis Peptide Therapy Product Offered

13.10.3 Novartis Peptide Therapy Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Novartis Main Business Overview

13.10.5 Novartis Latest Developments

13.11 Takeda

13.11.1 Takeda Company Information

13.11.2 Takeda Peptide Therapy Product Offered

13.11.3 Takeda Peptide Therapy Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Takeda Main Business Overview

13.11.5 Takeda Latest Developments

13.12 Ferring

13.12.1 Ferring Company Information

13.12.2 Ferring Peptide Therapy Product Offered

13.12.3 Ferring Peptide Therapy Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Ferring Main Business Overview

13.12.5 Ferring Latest Developments

13.13 AbbVie

13.13.1 AbbVie Company Information

13.13.2 AbbVie Peptide Therapy Product Offered

13.13.3 AbbVie Peptide Therapy Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 AbbVie Main Business Overview

13.13.5 AbbVie Latest Developments

13.14 Heinis

13.14.1 Heinis Company Information

13.14.2 Heinis Peptide Therapy Product Offered

13.14.3 Heinis Peptide Therapy Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Heinis Main Business Overview

13.14.5 Heinis Latest Developments

13.15 Hemmo

13.15.1 Hemmo Company Information

13.15.2 Hemmo Peptide Therapy Product Offered

13.15.3 Hemmo Peptide Therapy Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Hemmo Main Business Overview

13.15.5 Hemmo Latest Developments

13.16 Emcure Pharmaceutical

13.16.1 Emcure Pharmaceutical Company Information

13.16.2 Emcure Pharmaceutical Peptide Therapy Product Offered

13.16.3 Emcure Pharmaceutical Peptide Therapy Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Emcure Pharmaceutical Main Business Overview

13.16.5 Emcure Pharmaceutical Latest Developments

13.17 Cipla

13.17.1 Cipla Company Information

13.17.2 Cipla Peptide Therapy Product Offered

13.17.3 Cipla Peptide Therapy Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Cipla Main Business Overview

13.17.5 Cipla Latest Developments

13.18 Gland Pharma

13.18.1 Gland Pharma Company Information

13.18.2 Gland Pharma Peptide Therapy Product Offered

13.18.3 Gland Pharma Peptide Therapy Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 Gland Pharma Main Business Overview

13.18.5 Gland Pharma Latest Developments

13.19 Troikaa Pharmaceuticals

13.19.1 Troikaa Pharmaceuticals Company Information

13.19.2 Troikaa Pharmaceuticals Peptide Therapy Product Offered

13.19.3 Troikaa Pharmaceuticals Peptide Therapy Sales, Revenue, Price and Gross Margin (2020-2022)

13.19.4 Troikaa Pharmaceuticals Main Business Overview

13.19.5 Troikaa Pharmaceuticals Latest Developments

13.20 Biological E

13.20.1 Biological E Company Information

13.20.2 Biological E Peptide Therapy Product Offered

13.20.3 Biological E Peptide Therapy Sales, Revenue, Price and Gross Margin (2020-2022)

13.20.4 Biological E Main Business Overview

13.20.5 Biological E Latest Developments

14 Research Findings and Conclusion

Table 1. Peptide Therapy Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Peptide Therapy Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Parenteral Route of Administration

Table 4. Major Players of Mucosal Route of Administration

Table 5. Major Players of Oral Route of Administration

Table 6. Major Players of Transdermal Route of Administration

Table 7. Global Peptide Therapy Sales by Type (2017-2022) & (K Units)

Table 8. Global Peptide Therapy Sales Market Share by Type (2017-2022)

Table 9. Global Peptide Therapy Revenue by Type (2017-2022) & ($ million)

Table 10. Global Peptide Therapy Revenue Market Share by Type (2017-2022)

Table 11. Global Peptide Therapy Sale Price by Type (2017-2022) & (US$/Unit)

Table 12. Global Peptide Therapy Sales by Application (2017-2022) & (K Units)

Table 13. Global Peptide Therapy Sales Market Share by Application (2017-2022)

Table 14. Global Peptide Therapy Revenue by Application (2017-2022)

Table 15. Global Peptide Therapy Revenue Market Share by Application (2017-2022)

Table 16. Global Peptide Therapy Sale Price by Application (2017-2022) & (US$/Unit)

Table 17. Global Peptide Therapy Sales by Company (2020-2022) & (K Units)

Table 18. Global Peptide Therapy Sales Market Share by Company (2020-2022)

Table 19. Global Peptide Therapy Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Peptide Therapy Revenue Market Share by Company (2020-2022)

Table 21. Global Peptide Therapy Sale Price by Company (2020-2022) & (US$/Unit)

Table 22. Key Manufacturers Peptide Therapy Producing Area Distribution and Sales Area

Table 23. Players Peptide Therapy Products Offered

Table 24. Peptide Therapy Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Peptide Therapy Sales by Geographic Region (2017-2022) & (K Units)

Table 28. Global Peptide Therapy Sales Market Share Geographic Region (2017-2022)

Table 29. Global Peptide Therapy Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Peptide Therapy Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Peptide Therapy Sales by Country/Region (2017-2022) & (K Units)

Table 32. Global Peptide Therapy Sales Market Share by Country/Region (2017-2022)

Table 33. Global Peptide Therapy Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Peptide Therapy Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Peptide Therapy Sales by Country (2017-2022) & (K Units)

Table 36. Americas Peptide Therapy Sales Market Share by Country (2017-2022)

Table 37. Americas Peptide Therapy Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Peptide Therapy Revenue Market Share by Country (2017-2022)

Table 39. Americas Peptide Therapy Sales by Type (2017-2022) & (K Units)

Table 40. Americas Peptide Therapy Sales Market Share by Type (2017-2022)

Table 41. Americas Peptide Therapy Sales by Application (2017-2022) & (K Units)

Table 42. Americas Peptide Therapy Sales Market Share by Application (2017-2022)

Table 43. APAC Peptide Therapy Sales by Region (2017-2022) & (K Units)

Table 44. APAC Peptide Therapy Sales Market Share by Region (2017-2022)

Table 45. APAC Peptide Therapy Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Peptide Therapy Revenue Market Share by Region (2017-2022)

Table 47. APAC Peptide Therapy Sales by Type (2017-2022) & (K Units)

Table 48. APAC Peptide Therapy Sales Market Share by Type (2017-2022)

Table 49. APAC Peptide Therapy Sales by Application (2017-2022) & (K Units)

Table 50. APAC Peptide Therapy Sales Market Share by Application (2017-2022)

Table 51. Europe Peptide Therapy Sales by Country (2017-2022) & (K Units)

Table 52. Europe Peptide Therapy Sales Market Share by Country (2017-2022)

Table 53. Europe Peptide Therapy Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Peptide Therapy Revenue Market Share by Country (2017-2022)

Table 55. Europe Peptide Therapy Sales by Type (2017-2022) & (K Units)

Table 56. Europe Peptide Therapy Sales Market Share by Type (2017-2022)

Table 57. Europe Peptide Therapy Sales by Application (2017-2022) & (K Units)

Table 58. Europe Peptide Therapy Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Peptide Therapy Sales by Country (2017-2022) & (K Units)

Table 60. Middle East & Africa Peptide Therapy Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Peptide Therapy Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Peptide Therapy Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Peptide Therapy Sales by Type (2017-2022) & (K Units)

Table 64. Middle East & Africa Peptide Therapy Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Peptide Therapy Sales by Application (2017-2022) & (K Units)

Table 66. Middle East & Africa Peptide Therapy Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Peptide Therapy

Table 68. Key Market Challenges & Risks of Peptide Therapy

Table 69. Key Industry Trends of Peptide Therapy

Table 70. Peptide Therapy Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Peptide Therapy Distributors List

Table 73. Peptide Therapy Customer List

Table 74. Global Peptide Therapy Sales Forecast by Region (2023-2028) & (K Units)

Table 75. Global Peptide Therapy Sales Market Forecast by Region

Table 76. Global Peptide Therapy Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Peptide Therapy Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Peptide Therapy Sales Forecast by Country (2023-2028) & (K Units)

Table 79. Americas Peptide Therapy Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Peptide Therapy Sales Forecast by Region (2023-2028) & (K Units)

Table 81. APAC Peptide Therapy Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Peptide Therapy Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Europe Peptide Therapy Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Peptide Therapy Sales Forecast by Country (2023-2028) & (K Units)

Table 85. Middle East & Africa Peptide Therapy Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Peptide Therapy Sales Forecast by Type (2023-2028) & (K Units)

Table 87. Global Peptide Therapy Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Peptide Therapy Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Peptide Therapy Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Peptide Therapy Sales Forecast by Application (2023-2028) & (K Units)

Table 91. Global Peptide Therapy Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Peptide Therapy Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Peptide Therapy Revenue Market Share Forecast by Application (2023-2028)

Table 94. Eli Lilly Basic Information, Peptide Therapy Manufacturing Base, Sales Area and Its Competitors

Table 95. Eli Lilly Peptide Therapy Product Offered

Table 96. Eli Lilly Peptide Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 97. Eli Lilly Main Business

Table 98. Eli Lilly Latest Developments

Table 99. AstraZeneca Basic Information, Peptide Therapy Manufacturing Base, Sales Area and Its Competitors

Table 100. AstraZeneca Peptide Therapy Product Offered

Table 101. AstraZeneca Peptide Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 102. AstraZeneca Main Business

Table 103. AstraZeneca Latest Developments

Table 104. Merck Basic Information, Peptide Therapy Manufacturing Base, Sales Area and Its Competitors

Table 105. Merck Peptide Therapy Product Offered

Table 106. Merck Peptide Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 107. Merck Main Business

Table 108. Merck Latest Developments

Table 109. Ipsen Basic Information, Peptide Therapy Manufacturing Base, Sales Area and Its Competitors

Table 110. Ipsen Peptide Therapy Product Offered

Table 111. Ipsen Peptide Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 112. Ipsen Main Business

Table 113. Ipsen Latest Developments

Table 114. Novo Nordisk Basic Information, Peptide Therapy Manufacturing Base, Sales Area and Its Competitors

Table 115. Novo Nordisk Peptide Therapy Product Offered

Table 116. Novo Nordisk Peptide Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 117. Novo Nordisk Main Business

Table 118. Novo Nordisk Latest Developments

Table 119. Teva Pharmaceutical Industries Basic Information, Peptide Therapy Manufacturing Base, Sales Area and Its Competitors

Table 120. Teva Pharmaceutical Industries Peptide Therapy Product Offered

Table 121. Teva Pharmaceutical Industries Peptide Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 122. Teva Pharmaceutical Industries Main Business

Table 123. Teva Pharmaceutical Industries Latest Developments

Table 124. Abbott Laboratories Basic Information, Peptide Therapy Manufacturing Base, Sales Area and Its Competitors

Table 125. Abbott Laboratories Peptide Therapy Product Offered

Table 126. Abbott Laboratories Peptide Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 127. Abbott Laboratories Main Business

Table 128. Abbott Laboratories Latest Developments

Table 129. Sanofi Basic Information, Peptide Therapy Manufacturing Base, Sales Area and Its Competitors

Table 130. Sanofi Peptide Therapy Product Offered

Table 131. Sanofi Peptide Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 132. Sanofi Main Business

Table 133. Sanofi Latest Developments

Table 134. J & J Basic Information, Peptide Therapy Manufacturing Base, Sales Area and Its Competitors

Table 135. J & J Peptide Therapy Product Offered

Table 136. J & J Peptide Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 137. J & J Main Business

Table 138. J & J Latest Developments

Table 139. Novartis Basic Information, Peptide Therapy Manufacturing Base, Sales Area and Its Competitors

Table 140. Novartis Peptide Therapy Product Offered

Table 141. Novartis Peptide Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 142. Novartis Main Business

Table 143. Novartis Latest Developments

Table 144. Takeda Basic Information, Peptide Therapy Manufacturing Base, Sales Area and Its Competitors

Table 145. Takeda Peptide Therapy Product Offered

Table 146. Takeda Peptide Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 147. Takeda Main Business

Table 148. Takeda Latest Developments

Table 149. Ferring Basic Information, Peptide Therapy Manufacturing Base, Sales Area and Its Competitors

Table 150. Ferring Peptide Therapy Product Offered

Table 151. Ferring Peptide Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 152. Ferring Main Business

Table 153. Ferring Latest Developments

Table 154. AbbVie Basic Information, Peptide Therapy Manufacturing Base, Sales Area and Its Competitors

Table 155. AbbVie Peptide Therapy Product Offered

Table 156. AbbVie Peptide Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 157. AbbVie Main Business

Table 158. AbbVie Latest Developments

Table 159. Heinis Basic Information, Peptide Therapy Manufacturing Base, Sales Area and Its Competitors

Table 160. Heinis Peptide Therapy Product Offered

Table 161. Heinis Peptide Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 162. Heinis Main Business

Table 163. Heinis Latest Developments

Table 164. Hemmo Basic Information, Peptide Therapy Manufacturing Base, Sales Area and Its Competitors

Table 165. Hemmo Peptide Therapy Product Offered

Table 166. Hemmo Peptide Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 167. Hemmo Main Business

Table 168. Hemmo Latest Developments

Table 169. Emcure Pharmaceutical Basic Information, Peptide Therapy Manufacturing Base, Sales Area and Its Competitors

Table 170. Emcure Pharmaceutical Peptide Therapy Product Offered

Table 171. Emcure Pharmaceutical Peptide Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 172. Emcure Pharmaceutical Main Business

Table 173. Emcure Pharmaceutical Latest Developments

Table 174. Cipla Basic Information, Peptide Therapy Manufacturing Base, Sales Area and Its Competitors

Table 175. Cipla Peptide Therapy Product Offered

Table 176. Cipla Peptide Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 177. Cipla Main Business

Table 178. Cipla Latest Developments

Table 179. Gland Pharma Basic Information, Peptide Therapy Manufacturing Base, Sales Area and Its Competitors

Table 180. Gland Pharma Peptide Therapy Product Offered

Table 181. Gland Pharma Peptide Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 182. Gland Pharma Main Business

Table 183. Gland Pharma Latest Developments

Table 184. Troikaa Pharmaceuticals Basic Information, Peptide Therapy Manufacturing Base, Sales Area and Its Competitors

Table 185. Troikaa Pharmaceuticals Peptide Therapy Product Offered

Table 186. Troikaa Pharmaceuticals Peptide Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 187. Troikaa Pharmaceuticals Main Business

Table 188. Troikaa Pharmaceuticals Latest Developments

Table 189. Biological E Basic Information, Peptide Therapy Manufacturing Base, Sales Area and Its Competitors

Table 190. Biological E Peptide Therapy Product Offered

Table 191. Biological E Peptide Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 192. Biological E Main Business

Table 193. Biological E Latest Developments

List of Figures

Figure 1. Picture of Peptide Therapy

Figure 2. Peptide Therapy Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Peptide Therapy Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Peptide Therapy Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Peptide Therapy Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Parenteral Route of Administration

Figure 10. Product Picture of Mucosal Route of Administration

Figure 11. Product Picture of Oral Route of Administration

Figure 12. Product Picture of Transdermal Route of Administration

Figure 13. Global Peptide Therapy Sales Market Share by Type in 2021

Figure 14. Global Peptide Therapy Revenue Market Share by Type (2017-2022)

Figure 15. Peptide Therapy Consumed in Cancer

Figure 16. Global Peptide Therapy Market: Cancer (2017-2022) & (K Units)

Figure 17. Peptide Therapy Consumed in Cardiovascular Diseases

Figure 18. Global Peptide Therapy Market: Cardiovascular Diseases (2017-2022) & (K Units)

Figure 19. Peptide Therapy Consumed in Gastrointestinal Disorders

Figure 20. Global Peptide Therapy Market: Gastrointestinal Disorders (2017-2022) & (K Units)

Figure 21. Peptide Therapy Consumed in Metabolic Disorders

Figure 22. Global Peptide Therapy Market: Metabolic Disorders (2017-2022) & (K Units)

Figure 23. Peptide Therapy Consumed in Others

Figure 24. Global Peptide Therapy Market: Others (2017-2022) & (K Units)

Figure 25. Global Peptide Therapy Sales Market Share by Application (2017-2022)

Figure 26. Global Peptide Therapy Revenue Market Share by Application in 2021

Figure 27. Peptide Therapy Revenue Market by Company in 2021 ($ Million)

Figure 28. Global Peptide Therapy Revenue Market Share by Company in 2021

Figure 29. Global Peptide Therapy Sales Market Share by Geographic Region (2017-2022)

Figure 30. Global Peptide Therapy Revenue Market Share by Geographic Region in 2021

Figure 31. Global Peptide Therapy Sales Market Share by Region (2017-2022)

Figure 32. Global Peptide Therapy Revenue Market Share by Country/Region in 2021

Figure 33. Americas Peptide Therapy Sales 2017-2022 (K Units)

Figure 34. Americas Peptide Therapy Revenue 2017-2022 ($ Millions)

Figure 35. APAC Peptide Therapy Sales 2017-2022 (K Units)

Figure 36. APAC Peptide Therapy Revenue 2017-2022 ($ Millions)

Figure 37. Europe Peptide Therapy Sales 2017-2022 (K Units)

Figure 38. Europe Peptide Therapy Revenue 2017-2022 ($ Millions)

Figure 39. Middle East & Africa Peptide Therapy Sales 2017-2022 (K Units)

Figure 40. Middle East & Africa Peptide Therapy Revenue 2017-2022 ($ Millions)

Figure 41. Americas Peptide Therapy Sales Market Share by Country in 2021

Figure 42. Americas Peptide Therapy Revenue Market Share by Country in 2021

Figure 43. United States Peptide Therapy Revenue Growth 2017-2022 ($ Millions)

Figure 44. Canada Peptide Therapy Revenue Growth 2017-2022 ($ Millions)

Figure 45. Mexico Peptide Therapy Revenue Growth 2017-2022 ($ Millions)

Figure 46. Brazil Peptide Therapy Revenue Growth 2017-2022 ($ Millions)

Figure 47. APAC Peptide Therapy Sales Market Share by Region in 2021

Figure 48. APAC Peptide Therapy Revenue Market Share by Regions in 2021

Figure 49. China Peptide Therapy Revenue Growth 2017-2022 ($ Millions)

Figure 50. Japan Peptide Therapy Revenue Growth 2017-2022 ($ Millions)

Figure 51. South Korea Peptide Therapy Revenue Growth 2017-2022 ($ Millions)

Figure 52. Southeast Asia Peptide Therapy Revenue Growth 2017-2022 ($ Millions)

Figure 53. India Peptide Therapy Revenue Growth 2017-2022 ($ Millions)

Figure 54. Australia Peptide Therapy Revenue Growth 2017-2022 ($ Millions)

Figure 55. Europe Peptide Therapy Sales Market Share by Country in 2021

Figure 56. Europe Peptide Therapy Revenue Market Share by Country in 2021

Figure 57. Germany Peptide Therapy Revenue Growth 2017-2022 ($ Millions)

Figure 58. France Peptide Therapy Revenue Growth 2017-2022 ($ Millions)

Figure 59. UK Peptide Therapy Revenue Growth 2017-2022 ($ Millions)

Figure 60. Italy Peptide Therapy Revenue Growth 2017-2022 ($ Millions)

Figure 61. Russia Peptide Therapy Revenue Growth 2017-2022 ($ Millions)

Figure 62. Middle East & Africa Peptide Therapy Sales Market Share by Country in 2021

Figure 63. Middle East & Africa Peptide Therapy Revenue Market Share by Country in 2021

Figure 64. Egypt Peptide Therapy Revenue Growth 2017-2022 ($ Millions)

Figure 65. South Africa Peptide Therapy Revenue Growth 2017-2022 ($ Millions)

Figure 66. Israel Peptide Therapy Revenue Growth 2017-2022 ($ Millions)

Figure 67. Turkey Peptide Therapy Revenue Growth 2017-2022 ($ Millions)

Figure 68. GCC Country Peptide Therapy Revenue Growth 2017-2022 ($ Millions)

Figure 69. Manufacturing Cost Structure Analysis of Peptide Therapy in 2021

Figure 70. Manufacturing Process Analysis of Peptide Therapy

Figure 71. Industry Chain Structure of Peptide Therapy

Figure 72. Channels of Distribution

Figure 73. Distributors Profiles